Rafael Alfonso, Director, Analytics and Innovation, Value Evidence and Outcomes, GSK

Rafael Alfonso at Evidence USA 2017

Rachel Anhorn, Director, Payer Policy and Health Outcomes, Foundation Medicine Inc

Bhakti Arondekar, Senior Director, Global & US Immuno/Oncology Team Leader, Outcomes & Evidence, Pfizer

Bhakti Arondekar at Evidence USA 2017

James Barbeau, Director of Clinical Pathology, Lifespan/Brown University

James Barbeau at Evidence USA 2017

Lauren Bartolome, HEOR Fellow, Novartis

Lauren Bartolome at Evidence USA 2017

Alberto Batista, HEOR Fellow, Jefferson College of Population Health

Alberto Batista at Evidence USA 2017

Elise Berliner, Ph.D., Director, Technology Assessment Programme, Agency for Healthcare Research and Quality - U.S. Department of Health and Human Services

Jason Booth, Global Health Economics and Outcomes Research Lead, Oncology, Shire Pharmaceuticals

Jason Booth at Evidence USA 2017

Jennifer Bragg, Partner, Skadden Arps Slate Meagher & Flom LLP

Bruce Broad, Clinical Professor of Dermatology at Perelman School of Medicine, University of Pennsylvania

Catherine Brownstein, Scientific Director, Manton Center for Orphan Disease Research

Catherine Brownstein at Evidence USA 2017

Hassan Bruneo, Associate Director, Alnylam

Hassan Bruneo at Evidence USA 2017

Anna Bucsics, Project Advisor, University of Vienna

Anna Bucsics at Evidence USA 2017

Francisco Burgin, PGY-1 Managed Care Pharmacy Resident, Humana

Francisco Burgin at Evidence USA 2017

Yong Chen, Director of Real World Data & Analytics, GSK

Yong Chen at Evidence USA 2017

Steve Clark, Vice President of Business Development and Consulting, Optum Life Sciences

Steve Clark at Evidence USA 2017

Aimee Coughlin, mktg, Optum Life Sciences

Aimee Coughlin at Evidence USA 2017

Mark Cziraky, Vice President of Researce Healthcore, Anthem

Mark Cziraky at Evidence USA 2017

Keely Dahl, Associate Medical Director Biologics, Novo Nordisk

Keely Dahl at Evidence USA 2017

David Davidovic, Founder, pathForward, Former VP and Global Head, Commercial Services, Roche Genentech

Jill Davies, COO, Gene Matters

Jill Davies at Evidence USA 2017

Peter Dehnel, Medical Director, Blue Cross and Blue Shield of Minnesota

Peter Dehnel at Evidence USA 2017

Riad Dirani, Riad Dirani, Vice President, Global Health Economics and Outcomes Research, Teva Pharmaceuticals

Tao Fan, Director of Evidence Based Medicine and Medical Affairs, Sanofi Inc

Tao Fan at Evidence USA 2017

Susan Gabriel, Director of Global Health Economics and Outcomes Research and Oncology, Teva Pharmaceutical Industries

Susan Gabriel at Evidence USA 2017

Julia Gaebler, Former Senior Director of Global Medical Outcomes Strategy, Biogen Idec

Pamela Gavin, Chief Operating Officer, National Organization for Rare Disorders

Pamela Gavin at Evidence USA 2017

Bill Goodson, Deputy Director of Pricing Reimbursement and Patient Assistance, Eisai

Andy Gunn, Global Head Evidence Generation, UCB Pharma

Andy Gunn at Evidence USA 2017

Michelle Guo, Manager Real World Data Scientist, GSK

Michelle Guo at Evidence USA 2017

James Harnett, Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value, Pfizer

James Harnett at Evidence USA 2017

Katherine Hempstead, Senior Adviser to the Executive Vice President, Robert Wood Johnson Foundation

Athula Herath, Global Head of Real world Evidence Disease Epidemiology, Novartis

Ravi Iyer, Director Global Health Economics and Reimbursement, Teva

Ravi Iyer at Evidence USA 2017

Jonathan Jarrow, Senior Medical Advisor to the Center Director of CDER, F.D.A

Ashley John, Senior Specialist, Advocacy and Policy, American Academy of Dermatology

Ashley John at Evidence USA 2017

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at Evidence USA 2017

Adam Kautzner, Vice President, Formulary & Drug Trends Solutions, Express Scripts

Adam Kautzner at Evidence USA 2017

Karen Keeley, Consultant, R.A.R.E. Science

Dan Klein, President and Chief Executive Officer, Patient Access Network Foundation

Olaf Koester, Director, Manitoba Health

Brett Kopelan, Executive Director, DebRa of America

Brett Kopelan at Evidence USA 2017

Shanthy Krishnaraja, Head of Global Health Economics and Reimbursement Strategy, C.S.L. Behring

Sonia Lee, HEOR Fellow, Ethicon Inc

Sonia Lee at Evidence USA 2017

Simon Lin, Chief Research Information Officer, Nationwide Children's Hospital

Simon Lin at Evidence USA 2017

Julie Locklear, Vice President and Head of Health Economics and Outcomes Research, EMD Serono

Julie Locklear at Evidence USA 2017

Ben locwin, Ex-Executive Director Roche President, Healthcare Science Advisors, Roche & Genentech

Ben locwin at Evidence USA 2017

Marianne Lopez, Research Director, Duke-Robert J. Margolis, MD, Center for Health Policy

Marianne Lopez at Evidence USA 2017

Christine Lu, Co-Director of the PRecisiOn Medicine Translational Research (PROMoTeR) Center, Harvard Pilgrim Health Care

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at Evidence USA 2017

Bill Martin, Vice President, Pharma Strategy and Account Management, Express Scripts and Accredo

John Maslowski, CEO, Fibrocell Science Inc

Christina Matteucci, Market Access Head, Brazil, Bristol Myers Squibb

Christina Matteucci at Evidence USA 2017

Kevin Mayo, Ex Senior Director, Global Patient (Market) Access - Commerical Strategy and Consumer Operations, Shire Pharmaceuticals

Kevin Mayo at Evidence USA 2017

Michele McCourt, Director, Cancer Care Co-Payment Assistance Foundation

Sean McElligott, Director, Market Access, Janssen

Sean McElligott at Evidence USA 2017

Jim McKay, Director, Clinical Development and Medical Affairs, Sandoz

Jim McKay at Evidence USA 2017

Timothy Miller, President, Chief Executive Officer and Director, Abeona Therapeutics Inc.

Timothy Miller at Evidence USA 2017

Roberta Monteiro, Market Access and Commercial Director Brazil, Eisai

Ramaiah Muthyala, Professor/Director at University of Minnesota, Indian Organisation of Rare Diseases

Ramaiah Muthyala at Evidence USA 2017

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at Evidence USA 2017

Douglas Nanton, Market Access and Government Affairs - Western Canada and Ottawa, Valeant Pharmaceuticals International

David Nash, MD MBA, Dean/Board of Directors, Jefferson College of Population Health

Amy Niles, Vice President, External Affairs, Patient Access Network Foundation P.A.N.

Meryem Nimour, VP- Medical Affairs Lead – Rare Disease- Emerging Markets,, Pfizer

Meryem Nimour at Evidence USA 2017

Nneka Onwudiwe PharmD PhD MBA, PRO/PE Regulatory Reviewer, US Government

Melissa Paige, UVA Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Sachin Palod, Vice President, Access & Value Solutions, Life Sciences, Optum Life Sciences

Sachin Palod at Evidence USA 2017

Leena Patel, President and CEO, Patient Access Network Foundation

Edmund Pezalla, Former VP Pharmaceutical Policy and Strategy, Aetna

Lisa Phelps, Director Community Relations and Marketing, National Organization for Rare Disorders

Lisa Phelps at Evidence USA 2017

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

S D Ravetkar, Executive Director, Serum Institute of India Ltd

S D Ravetkar at Evidence USA 2017

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at Evidence USA 2017

Elizabeth Richardson, Managing Associate, Duke Margolis Center for Health Policy

Elizabeth Richardson at Evidence USA 2017

Tehseen Salimi, Head of Medical Affairs-Primary Care and Women's Health, Merck

Tehseen Salimi at Evidence USA 2017

John Shea, Director Corporate Development, Merck & Co Inc

John Shea at Evidence USA 2017

Vanja Sikirica, Senior Director of Value Evidence and Outcomes, GlaxoSmithKline

Vanja Sikirica at Evidence USA 2017

Jason Simeone, Research Scientist, Real-World Evidence, Evidera

Jamie Skipper, Former, ONC - Patient Centered Outcomes Research/HIT Policy, HSS

David Smith, Professor of Laboratory Medicine And Pathology, Mayo Clinic

David Smith at Evidence USA 2017

Stephen Smith, Reimbursement Associate, Merck

Stephen Smith at Evidence USA 2017

Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center

John Stoeckle, Physician, Thomas Jefferson University Hospitals, Inc.

John Stoeckle at Evidence USA 2017

Erika Szabo, Associate Director of Global Oncology, Teva Pharmaceuticals

Erika Szabo at Evidence USA 2017

Dr Boxiong Tang, Senior Director, Teva Pharmaceuticals United State of America

Asif Velani, Head of Market Access, Puma

Asif Velani at Evidence USA 2017

Christine Verini, Chief Business Development Officer, CancerCare

Christine Verini at Evidence USA 2017

Jennifer Voelker, Post-doctoral HEOR fellow, Jansen

Jennifer Voelker at Evidence USA 2017

Bert Vrijhoef, CIO & Senior Principal Investigator, Panaxea & Maastricht Unniversity Medical Center

Bert Vrijhoef at Evidence USA 2017

Meredith Wadman, Policy Reporter, Science Magazine and author: The Vaccine Race: Science, Politics and the Human Costs of Defeating Disease., Viking

Surrey Walton, Associate Professor of Pharmacy Administration, U.I.C.

Christina Waters, President & Chief Executive Officer, R.A.R.E. Science

Christina Waters at Evidence USA 2017

Durhane Wong-Rieger, President and Chief Executive Officer, Canadian Organization For Rare Disorders

James Wu, Senior Manager, Global Health Economics, Amgen Inc

James Wu at Evidence USA 2017

Ying Wu, Director HEOR, Teva

Ying Wu at Evidence USA 2017

George Wyatt, Managing Director and Founder, Wyatt Health

George Wyatt at Evidence USA 2017